羟氯喹--抗疟消炎药

Indian Journal Of Clinical Practice Pub Date : 2024-05-06 DOI:10.59793/ijcp.v24i4.963

CR Anand, Moses

{"title":"羟氯喹--抗疟消炎药","authors":"CR Anand, Moses","doi":"10.59793/ijcp.v24i4.963","DOIUrl":null,"url":null,"abstract":"Hydroxychloroquine – a quinoline antimalarial, has hypoglycemic effects that manifest due toits action on the intracellular insulin metabolism in peripheral tissues. Recent studies confirmthat the use of Hydroxychloroquine can aid in preventing new onset diabetes and complicationsof diabetes, systemic lupus erythematosus and rheumatoid arthritis, as well as in improvingthe mortality rate of these patients","PeriodicalId":506647,"journal":{"name":"Indian Journal Of Clinical Practice","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hydroxychloroquine - An Antimalarial and Anti-inflammatory Drug\",\"authors\":\"CR Anand, Moses\",\"doi\":\"10.59793/ijcp.v24i4.963\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hydroxychloroquine – a quinoline antimalarial, has hypoglycemic effects that manifest due toits action on the intracellular insulin metabolism in peripheral tissues. Recent studies confirmthat the use of Hydroxychloroquine can aid in preventing new onset diabetes and complicationsof diabetes, systemic lupus erythematosus and rheumatoid arthritis, as well as in improvingthe mortality rate of these patients\",\"PeriodicalId\":506647,\"journal\":{\"name\":\"Indian Journal Of Clinical Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal Of Clinical Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.59793/ijcp.v24i4.963\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal Of Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59793/ijcp.v24i4.963","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

羟氯喹（Hydroxychloroquine）是一种喹啉类抗疟药物，具有降血糖作用，这主要是由于它对外周组织细胞内胰岛素代谢的作用。最近的研究证实，使用羟氯喹有助于预防新发糖尿病和糖尿病并发症、系统性红斑狼疮和类风湿性关节炎，并能提高这些患者的死亡率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Hydroxychloroquine - An Antimalarial and Anti-inflammatory Drug

Hydroxychloroquine – a quinoline antimalarial, has hypoglycemic effects that manifest due toits action on the intracellular insulin metabolism in peripheral tissues. Recent studies confirmthat the use of Hydroxychloroquine can aid in preventing new onset diabetes and complicationsof diabetes, systemic lupus erythematosus and rheumatoid arthritis, as well as in improvingthe mortality rate of these patients

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Indian Journal Of Clinical Practice

自引率

0.00%

发文量